Envestnet Asset Management Inc. Purchases 7,149 Shares of Cryoport, Inc. (NASDAQ:CYRX)

Envestnet Asset Management Inc. increased its position in shares of Cryoport, Inc. (NASDAQ:CYRXGet Rating) by 10.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 76,196 shares of the consumer goods maker’s stock after buying an additional 7,149 shares during the period. Envestnet Asset Management Inc. owned 0.15% of Cryoport worth $2,361,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. GW&K Investment Management LLC raised its stake in Cryoport by 3.7% during the first quarter. GW&K Investment Management LLC now owns 799,732 shares of the consumer goods maker’s stock worth $27,919,000 after buying an additional 28,415 shares during the last quarter. DnB Asset Management AS bought a new stake in Cryoport in the second quarter valued at $455,000. WCM Investment Management LLC increased its stake in Cryoport by 11.4% in the first quarter. WCM Investment Management LLC now owns 165,912 shares of the consumer goods maker’s stock valued at $5,792,000 after purchasing an additional 16,938 shares in the last quarter. Moody Aldrich Partners LLC increased its stake in Cryoport by 42.8% in the first quarter. Moody Aldrich Partners LLC now owns 135,856 shares of the consumer goods maker’s stock valued at $4,743,000 after purchasing an additional 40,734 shares in the last quarter. Finally, BerganKDV Wealth Management LLC increased its stake in Cryoport by 28.0% in the first quarter. BerganKDV Wealth Management LLC now owns 8,000 shares of the consumer goods maker’s stock valued at $279,000 after purchasing an additional 1,750 shares in the last quarter. Institutional investors own 90.33% of the company’s stock.

Analysts Set New Price Targets

CYRX has been the subject of several research analyst reports. KeyCorp decreased their price target on shares of Cryoport from $52.00 to $40.00 and set an “overweight” rating for the company in a research note on Friday, November 4th. B. Riley decreased their price target on shares of Cryoport from $55.00 to $30.00 and set a “buy” rating for the company in a research note on Wednesday. SVB Leerink decreased their price target on shares of Cryoport from $45.00 to $28.00 and set an “outperform” rating for the company in a research note on Friday, November 4th. Finally, Needham & Company LLC reduced their price objective on shares of Cryoport from $49.00 to $28.00 and set a “buy” rating for the company in a report on Friday, November 4th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $42.17.

Cryoport Stock Down 8.0 %

Shares of NASDAQ CYRX opened at $18.54 on Friday. Cryoport, Inc. has a 1 year low of $15.79 and a 1 year high of $75.00. The stock has a market capitalization of $908.46 million, a P/E ratio of -3.01 and a beta of 1.29. The company has a 50-day moving average price of $25.25 and a 200-day moving average price of $29.13. The company has a debt-to-equity ratio of 0.75, a current ratio of 14.96 and a quick ratio of 14.35.

Cryoport Profile

(Get Rating)

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.

Further Reading

Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cryoport, Inc. (NASDAQ:CYRXGet Rating).

Institutional Ownership by Quarter for Cryoport (NASDAQ:CYRX)

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.